CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic

[1]  CARDIAC SOCIETY OF AUSTRALIA AND NEW ZEALAND , 1976, Heart, Lung and Circulation.

[2]  P. Barlis,et al.  Consensus Guidelines for Interventional Cardiology Services Delivery During COVID-19 Pandemic in Australia and New Zealand , 2020, Heart, Lung and Circulation.

[3]  F. Apple,et al.  Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin I. , 2019, Journal of the American College of Cardiology.

[4]  J. Greenslade,et al.  Evaluating Rapid Rule-out of Acute Myocardial Infarction Using a High-Sensitivity Cardiac Troponin I Assay at Presentation. , 2018, Clinical chemistry.

[5]  J. Greenslade,et al.  Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome , 2017, JAMA.

[6]  J. Greenslade,et al.  Implementing change: evaluating the Accelerated Chest pain Risk Evaluation (ACRE) project , 2017, The Medical journal of Australia.

[7]  J. Greenslade,et al.  Improved Assessment of Chest pain Trial (IMPACT): assessing patients with possible acute coronary syndromes , 2017, The Medical journal of Australia.

[8]  Joanna M. Young,et al.  Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis. , 2017, Annals of internal medicine.

[9]  I. Scott,et al.  National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016. , 2016, Heart, lung & circulation.

[10]  R Ruthazer,et al.  Missed diagnoses of acute cardiac ischemia in the emergency department. , 2000, The New England journal of medicine.

[11]  Robert Woolard,et al.  Missed Diagnoses of Acute Cardiac Ischemia in the Emergency Department , 2000 .